chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Nasopharyngitis
Clinical narrative: Cold; Flu symtoms; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included spinal cord injury (SCI) and allergy to IVP dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included lisinopril 10 mg (MANUFACTURER UNKNOWN) for unknown indication on an unknown date. On 02Apr2021, the patient experienced cold and flu symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events cold and flu symptoms was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain
Clinical narrative: Swelling under left armpit; Sharp pain; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 29Mar2021 at 08:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) of 81mg, loratadine (MANUFACTURER UNKNOWN) and olmesartan (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 at 08:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 06:00, 48 hours after the shot, the patient experienced swelling under left armpit size of his open palm and sharp pain for four days till the time of reporting. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of swelling under left armpit and sharp pain were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: started vomiting; Massive headache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 01Apr2021 at 15:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had known allergy to sulfa drug. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not tested for COVID-19. On 02Apr2021 at 02:30 about 36 hours after the vaccine, the patient started vomiting and had a massive headache. The vomiting lasted for about 7 hours and the headache had not left as of 04Apr2021 09:00. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomiting was recovered with sequelae on 03Apr2021. The clinical outcome of the event massive headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Vaccination site pain, Vaccination site swelling
Clinical narrative: pain at injection site; swelling at injection site; sore left arm; sore elbow joints (both arms); This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included persistent atrial fibrillation. The patient had no known allergies. Concomitant medications included acetylsalicylic acid (ASPRIN 18 mg) from unknown date for unknown indication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6204) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did received other vaccines within four weeks prior to the vaccination. On 26Mar2021 the patient experienced pain at vaccination site, swelling at vaccination site, sore left arm and sore elbow joints (both arms). The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events pain at vaccination site, swelling at vaccination site, sore left arm and sore elbow joints was recovered on unknown date.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Feeling hot, Flushing
Clinical narrative: feeling hot; flushed with chills; strong stomach pain; Chills; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion hydrochloride (MANUFACTURER UNKNOWN) 150 of unspecified units and omeprazole (MANUFACTURER UNKNOWN) 20 of unspecified units, both from an unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 12:00, the patient experienced feeling hot, flushed, stomach pain and chills. Its reported that the patient felt hot and flushed with chills and strong stomach pain lasting all day (it was day 12 of it at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the reported events and included treatment with tylenol (MANUFACTURER UNKNOWN) and pepto bismol (MANUFACTURER UNKNOWN). The clinical outcome of the events of feeling hot, flushed, stomach pain and chills were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hyperaesthesia, Pruritus, Swelling
Clinical narrative: third toe of right foot, with some slight swellingand redness; third toe of right foot, with some slight swellingand redness; Itchy; Sensitive to touch; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included drospirenone; ethinylestradiol betadex clathrate (YAZ) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 10Mar2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient thought she might be developing COVID toes which was started on the third toe of her right foot, with some slight swelling and redness. It was itchy but sensitive to touch. The patient thought it was a bug bite, but now it was starting to develop on the same toe of her left foot. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events third toe of right foot, with some slight swelling and redness, itchy and sensitive to touch was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Paraesthesia
Clinical narrative: Nausea; Pain in arm; Tingling  in arm & left side; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 28Mar2021(at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included HIV and sulfonamide allergy. Concomitant medications included mirtazapine (MANUFACTURER UNKNOWN), raltegravir (ISENTRESS), emtricitabine, tenofovir alafenamide fumarate (DESCOVY), metoprolol (MANUFACTURER UNKNOWN) and hydrocortisone (HYDROXY); all from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 28Feb2021 at 13:15, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced pain/tingling in arm & left side. On an unknown date in Apr2021, 1 week after injection, the patient experienced nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain/tingling in arm & left side and nausea were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Discomfort, Insomnia, Joint stiffness
Clinical narrative: Extremely uncomfortable; Difficult to sleep; Joints became painful; Stiff joint; Inflamed joints; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 03Apr2021 at 00:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included sore joints since caught COVID in Mar2020 and COVID-19 in Mar2020. The patient had no known allergies to medications, food, or other products. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and cannabidiol (CBD OIL); all taken for unknown indication from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 14:00, the patient experienced most of the joints became painful, stiff and inflamed all night, making it difficult to sleep. On 04Apr2021, 22 hours after getting first vaccine shot, the patient was extremely uncomfortable. After the patient took the vaccine, her joints felt notably far more painful, more like they felt last spring and summer at their worst. The patient stated her joint problem was likely a COVID long-hauler condition. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events most of the joints became painful, stiff and inflamed all night, making it difficult to sleep and extremely uncomfortable was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Pyrexia, Swelling
Clinical narrative: fever; big lump under left armpit; swollen neck left armpit; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm left on 30Mar2021 at 18:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to food, medications, or other products. The patient previously the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 09Mar2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 13:00 the patient experienced fever, big lump under left armpit and swollen neck. The patient did not receive any treatment for the event. Events had not resulted in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, big lump under left armpit and swollen neck left armpit was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Gait disturbance, Paraesthesia
Clinical narrative: Very dizzy; disoriented; tingling in fingers, hands, feet; Difficulty walking; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 18:00, after 435 minutes of vaccination, the patient experienced very dizzy, disoriented, tingling in fingers, hands, feet and difficulty in walking. It was unknown if the patient received treatment for the reported events. The events did result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events very dizzy, disoriented, tingling in fingers, hands, feet and difficulty in walking were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Ultrasound breast, Vaccination site pain
Clinical narrative: mildly enlarged axillary lymph nodes; Pain radiating to entire arm and hand; Very intense pain at injection site; Pain radiating to entire arm and hand; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL8982) via an unspecified route of administration in the left arm on 28Jan2021 at 14:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis and penicillin allergy. Concomitant medications were reported as not applicable. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3248) via an unspecified route of administration in the left arm on 08Jan2021 at 14:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 29Jan2021 at 02:00, approximately 12 hours after injection of 2nd dose, the patient experienced very intense pain at injection site and the pain radiated to entire arm and hand. The intense pain persists at injection site over 2 months post injection. The pain in left arm was causing limited motion range. Occasionally mostly during the night, very intense pain reoccurs at the time of report. On an unknown date in Feb2021, the patient experienced mildly enlarged axillary lymph nodes. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  On an unknown date in Feb2021 one week after 2nd dose, the patient underwent routing breast ultrasound screening and the result was mildly enlarged axillary lymph nodes. The clinical outcome of the events very intense pain at injection site, pain radiating to entire arm and hand, enlarged axillary lymph nodes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Dyspnoea, Headache, Lymphadenopathy, Odynophagia
Clinical narrative: Swollen lymph node in neck on left side; Swallowing painful; Breathing slightly strained; Headache; Fluctuating body temperature; Had expected amount of soreness on day 2.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to opioids and unbromated corn. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Concomitant medications included a herbal allergy tincture by Allertonic. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced an expected amount of soreness. On 31Mar2021 at 14:00 the patient experienced swollen lymph node in neck on left side (same side as shot) that was extreme enough to make swallowing painful and breathing slightly strained, accompanied by headache and fluctuating body temperature. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for adverse events. The clinical outcome of the event swollen lymph node in neck on left side, swallowing painful, breathing slightly strained, headache and fluctuating body temperature was recovered on 03Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Swollen lymph node in neck on left side; Swallowing painful; Breathing slightly strained; Headache; Fluctuating body temperature; Had expected amount of soreness on day 2.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to opioids and unbromated corn. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Concomitant medications included a herbal allergy tincture by Allertonic. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced an expected amount of soreness. On 31Mar2021 at 14:00 the patient experienced swollen lymph node in neck on left side (same side as shot) that was extreme enough to make swallowing painful and breathing slightly strained, accompanied by headache and fluctuating body temperature. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for adverse events. The clinical outcome of the event swollen lymph node in neck on left side, swallowing painful, breathing slightly strained, headache and fluctuating body temperature was recovered on 03Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Severe difficulty in breathing/shortness of breath; chest pains; This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ew0151), via an unspecified route of administration, administered in the left arm on 03Apr2021 14:00 (at the age of 57 years old) as dose 1, single for COVID-19 immunization. Medical history included angina, asthma, sleep apnea and carotid artery spasm, all from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient previously took codeine and ace inhibitors and experienced drug allergies for both. The patient experienced severe difficulty in breathing/shortness of breath and chest pains on 03Apr2021 14:15. It was reported that the patient experienced severe difficulty in breathing chest pains shortness of breath. He was taken from site to hospital via ambulance and they gave him a hundred percent oxygen and they gave him shots to counteract the severe side effects from the vaccine. The adverse event result in emergency room/department or urgent care. Treatment received included oxygen IVs and four shots. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Somnolence, Tinnitus
Clinical narrative: have been experiencing high pitched whistling in ears; tend to fall asleep in the middle of the day; have little energy; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 10:00 (at the age of 73-year-old), as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 73-year-old), as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus for 50 years. The patient had no known allergies to medications, food, or other products. Concomitant medications included insulin lispro (HUMALOG), insulin glargine (LANTUS), atenolol (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and simvastatin (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 10:00, the patient had been experiencing high pitched whistling in ears, tend to fall asleep in the middle of the day and had little energy. The patient does not normally fall asleep in the middle of the day. The patient was retired; however, he paints houses, work on cars and play with grandchildren. So, what the patient was experiencing was not normal. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events high pitched whistling in ears, tend to fall asleep in the middle of the day and little energy was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Major diarrhea; This is a spontaneous report from a non contactable consumer, the patient. A 27-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) in the arm left on 03Apr2021, at 11:30, (at the age of 27-years-old) as a dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 the patient experienced major diarrhea. No therapeutic measures were taken as a result of reported event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event major diarrhea was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Feeling abnormal, Headache, Heart rate increased, Insomnia
Clinical narrative: Fast heartbeat; Feels like pure adrenaline pumping through body wired tense sensation; Pain like fire in ears; Pain in throat; Nose pain; Strange headache; Muscle soreness; insomnia; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 02Apr2021 at 11:00(at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included thyroid disorder, hypotension, rheumatoid arthritis and rheumatoid arthritis. Concomitant medications included withania somnifera (ASHWAGANDHA), sambucus nigra (IMMUNITY), probiotic (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), all started on unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, the patient experienced feel like pure adrenaline pumping through body wired tense sensation, pain like fire in ears, muscle soreness, fast heartbeat., pain in throat, nose pain, strange headache. Two days later now, the patient felt like it must come off 3-day meth binge. The patient did not receive any treatment for events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event weird feeling, pain like fire in ears, muscle soreness, fast heartbeat, pain in throat, nose pain, strange headache was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Rhinalgia
Clinical narrative: Fast heartbeat; Feels like pure adrenaline pumping through body wired tense sensation; Pain like fire in ears; Pain in throat; Nose pain; Strange headache; Muscle soreness; insomnia; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 02Apr2021 at 11:00(at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included thyroid disorder, hypotension, rheumatoid arthritis and rheumatoid arthritis. Concomitant medications included withania somnifera (ASHWAGANDHA), sambucus nigra (IMMUNITY), probiotic (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), all started on unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, the patient experienced feel like pure adrenaline pumping through body wired tense sensation, pain like fire in ears, muscle soreness, fast heartbeat., pain in throat, nose pain, strange headache. Two days later now, the patient felt like it must come off 3-day meth binge. The patient did not receive any treatment for events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event weird feeling, pain like fire in ears, muscle soreness, fast heartbeat, pain in throat, nose pain, strange headache was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Muscle strain, Pain, Pain in extremity
Clinical narrative: Unable to bring arm above shoulder height; Very painful arm/shoulder like; Very painful arm/shoulder; like a pull muscle; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the right arm on 23Dec2020 at 17:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy. It was reported that patient was healthy. It was reported that patient received other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Dec2020 at 20:00, the patient experienced pain upon movement, shoulder pain, painful arm and pulled muscle. The patient described that as very painful arm/shoulder like, no soreness but more like a pull muscle for two and half days and unable to bring arm above shoulder height. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse event. The clinical outcome of the events pain upon movement, shoulder pain, painful arm and pulled muscle was recovered on an unknown date in Dec2020.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Severe hives (weeping), onset 48-hours post-injection. Lasted 11-days.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), and omeprazole (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 14:00 the patient experienced Severe hives (weeping), onset 48-hours post-injection. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever 101.2; Body aches; Chills; Headache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 14:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included carvedilol (MANUFACTURER UNKNOWN) taken from an unknown date for an unknown indication and lisinopril (MANUFACTURER UNKNOWN) taken from an unknown date for an unknown indication. The patient previously received codeine and opiates and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 13Mar2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 04Apr2021 at 05:30, the patient experienced a fever 101.2 (unspecified units), body aches, chills and headache. The events did not result in a doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events fever 101.2 (unspecified units), body aches, chills and headache were resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Fatigue, Headache, Injection site hypoaesthesia
Clinical narrative: Injection site and surrounding arm felt like a rock; Dizziness; Overall achy; Mild wheezing; Chest tightness; Mild headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route in the right arm on 01Apr2021 at 12:30 (at an age of 28-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had medical history of asthma, anxiety, depression, ADHD (attention deficit hyperactivity disorder), peanut allergy and food allergy to legumes. The patient had known allergy to past drug VICODIN. Concomitant medications included birth control medications, montelukast (MANUFACTURER UNKNOWN), fluticasone propionate and salmeterol xinafoate (ADVAIR), esomeprazole (MANUFACTURER UNKNOWN) started on an unknown date for unknown indications. The patient did not receive any other vaccination within four weeks prior to the COVID vaccine. Post the vaccination, the patient was not tested for COVID-19. On 01Apr2021 at 15:00, the patient experienced fatigue, dizziness, overall achy, mild headache, mild wheezing and chest tightness. On 02Apr2021, the patient's injection site and surrounding arm felt like a rock. No treatment was given for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events of injection site and surrounding arm felt like a rock, fatigue, dizziness, overall achy, mild headache, mild wheezing and chest tightness were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Wheezing
Clinical narrative: Injection site and surrounding arm felt like a rock; Dizziness; Overall achy; Mild wheezing; Chest tightness; Mild headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route in the right arm on 01Apr2021 at 12:30 (at an age of 28-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had medical history of asthma, anxiety, depression, ADHD (attention deficit hyperactivity disorder), peanut allergy and food allergy to legumes. The patient had known allergy to past drug VICODIN. Concomitant medications included birth control medications, montelukast (MANUFACTURER UNKNOWN), fluticasone propionate and salmeterol xinafoate (ADVAIR), esomeprazole (MANUFACTURER UNKNOWN) started on an unknown date for unknown indications. The patient did not receive any other vaccination within four weeks prior to the COVID vaccine. Post the vaccination, the patient was not tested for COVID-19. On 01Apr2021 at 15:00, the patient experienced fatigue, dizziness, overall achy, mild headache, mild wheezing and chest tightness. On 02Apr2021, the patient's injection site and surrounding arm felt like a rock. No treatment was given for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events of injection site and surrounding arm felt like a rock, fatigue, dizziness, overall achy, mild headache, mild wheezing and chest tightness were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vertigo
Clinical narrative: Dizziness; vertigo; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and allergies were not reported. The patient did not receive any concomitant medications within two weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 the patient experienced dizziness, vertigo and nausea. The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events dizziness, vertigo and nausea were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Vaccination site pain
Clinical narrative: Cough; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 80-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 80-year-old), as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, bypass surgery, mitral valve replacement, chronic obstructive pulmonary disease (COPD) and COVID-19 and hospitalisation (due to COVID-19) in Dec2020 and did not suffer as much pain and discomfort as the side effects. The patient was not aware of any known allergies to medications, food or other products. Concomitant medications included warfarin (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and torsemide (TORSEMIDE), all medications received on unknown date for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced cough and soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events cough and soreness at injection site was resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Malaise
Clinical narrative: Headache; Feeling unwell; sore arm; Dizziness,; Nausea; Fatigue; Joint pain.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 at 16:00 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and allergy to formaldehyde(allergy to chemical). Concomitant medications included topical steroids (unspecified medication) for psoriatic lesions. The patient previously took cephalexin (KEFLEX), amoxicillin, clavulanic acid (AUGMENTIN), sulfamethoxazole, trimethoprim (BACTRIM) and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 20:00 within four hours of vaccination, the patient experienced dizziness, nausea, fatigue and joint pain. On 04Apr2021 at 04:00 after 12 hours, the patient experienced headache, fatigue, feeling unwell and sore arm(pain in arm). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events dizziness, nausea, fatigue, joint pain, headache, feeling unwell and sore arm were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Headache; Feeling unwell; sore arm; Dizziness,; Nausea; Fatigue; Joint pain.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 at 16:00 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and allergy to formaldehyde(allergy to chemical). Concomitant medications included topical steroids (unspecified medication) for psoriatic lesions. The patient previously took cephalexin (KEFLEX), amoxicillin, clavulanic acid (AUGMENTIN), sulfamethoxazole, trimethoprim (BACTRIM) and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 20:00 within four hours of vaccination, the patient experienced dizziness, nausea, fatigue and joint pain. On 04Apr2021 at 04:00 after 12 hours, the patient experienced headache, fatigue, feeling unwell and sore arm(pain in arm). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events dizziness, nausea, fatigue, joint pain, headache, feeling unwell and sore arm were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.